ABNORMAL LYSOSOMAL CATHEPSIN ACTIVITIES IN LEUKOCYTES AND CULTURED SKIN FIBROBLASTS IN LATE INFANTILE, BUT NOT IN JUVENILE NEURONAL CEROID-LIPOFUSCINOSIS (BATTEN DISEASE)

被引：10
|
作者：
BENNETT, MJ
CHERN, L
CARPENTER, KH
SLADKY, JT
机构：
[1] CHILDRENS HOSP, DEPT PEDIAT, PHILADELPHIA, PA 19104 USA
[2] CHILDRENS HOSP, DEPT CHEM PATHOL, SHEFFIELD S10 2TH, S YORKSHIRE, ENGLAND
来源：
CLINICA CHIMICA ACTA | 1992年 / 208卷 / 1-2期
关键词：
NEURONAL CEROID-LIPOFUSCINOSIS; BATTEN DISEASE; CATHEPSINS; LYSOSOMAL PROTEASES;
D O I：
10.1016/0009-8981(92)90028-O
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：111 / 117
页数：7
相关论文
共 45 条
  • [31] A novel assay for lysosomal pepstatin-insensitive proteinase and its application for the diagnosis of late-infantile neuronal ceroid lipofuscinosis
    Junaid, MA
    Brooks, SS
    Wisniewski, KE
    Pullarkat, RK
    CLINICA CHIMICA ACTA, 1999, 281 (1-2) : 169 - 176
  • [32] Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase
    Ezaki, J
    Takeda-Ezaki, M
    Kominami, E
    JOURNAL OF BIOCHEMISTRY, 2000, 128 (03) : 509 - 516
  • [33] A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae:: A model to study Batten disease
    Guo, WX
    Mao, CG
    Obeid, LM
    Boustany, RM
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1999, 19 (05) : 671 - 680
  • [34] A Disrupted Homologue of the Human CLN3 or Juvenile Neuronal Ceroid Lipofuscinosis Gene in Saccharomyces cerevisiae: A Model to Study Batten Disease
    Wei-Xing Guo
    Cungui Mao
    Lina M. Obeid
    Rose-Mary Boustany
    Cellular and Molecular Neurobiology, 1999, 19 : 671 - 680
  • [35] Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosis
    Sharifi, A.
    Kousi, M.
    Sagne, C.
    Bellenchi, G. C.
    Morel, L.
    Darmon, M.
    Hulkova, H.
    Ruivo, R.
    Debacker, C.
    El Mestikawy, S.
    Elleder, M.
    Lehesjoki, A. -E.
    Jalanko, A.
    Gasnier, B.
    Kyttala, A.
    HUMAN MOLECULAR GENETICS, 2010, 19 (22) : 4497 - 4514
  • [36] Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis
    Sleat, David E.
    El-Banna, Mukarram
    Sohar, Istvan
    Kim, Kwi-Hye
    Dobrenis, Kostantin
    Walkley, Steven U.
    Lobel, Peter
    MOLECULAR GENETICS AND METABOLISM, 2008, 94 (02) : 222 - 233
  • [37] The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis
    Kopan, S
    Sivasubramaniam, U
    Warburton, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (01) : 58 - 65
  • [38] Purification and characterization of bovine brain lysosomal pepstatin-insensitive proteinase, the gene product deficient in the human late-infantile neuronal ceroid lipofuscinosis
    Junaid, MA
    Wu, GX
    Pullarkat, RK
    JOURNAL OF NEUROCHEMISTRY, 2000, 74 (01) : 287 - 294
  • [39] Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
    Katz, Martin L.
    Coates, Joan R.
    Sibigtroth, Christine M.
    Taylor, Jacob D.
    Carpentier, Melissa
    Young, Whitney M.
    Wininger, Fred A.
    Kennedy, Derek
    Vuillemenot, Brian R.
    O'Neill, Charles A.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2014, 92 (11) : 1591 - 1598
  • [40] The value of positron emission tomography in the diagnosis and monitoring of late infantile and juvenile lipopigment storage disorders (so-called Batten or neuronal ceroid lipofuscinoses)
    Philippart, M
    daSilva, E
    Chugani, HT
    NEUROPEDIATRICS, 1997, 28 (01) : 74 - 76
12345